28784051|t|Pomegranate ellagitannin-gut microbial-derived metabolites, urolithins, inhibit neuroinflammation in vitro.
28784051|a|OBJECTIVES: Urolithins, ellagitannin-gut microbial-derived metabolites, have been reported to mediate pomegranate's neuroprotective effects against Alzheimer's disease (AD), but there are limited data on their effects against neuroinflammation. Herein, we: (1) evaluated whether urolithins (urolithins A and B and their methylated derivatives) attenuate neuroinflammation in murine BV-2 microglia and human SH-SY5Y neurons, and (2) evaluated hippocampus of transgenic AD (R1.40) mice administered a pomegranate extract (PE; 100 or 200 mg/kg/day for 3 weeks) for inflammatory biomarkers. METHODS: Effects of urolithins (10 muM) on inflammatory biomarkers were evaluated in lipopolysaccharide (LPS)-stimulated BV-2 microglia. In a non-contact co-culture cell model, SH-SY5Y cell viability was assessed after exposure to media collected from LPS-BV-2 cells treated with or without urolithins. Effects of urolithins on apoptosis and caspase 3/7 and 9 release from H2O2-induced oxidative stress of BV-2 and SH-SY5Y cells were assessed. Hippocampal tissues of vehicle and PE-treated transgenic R1.40 mice were evaluated for gene expression of inflammatory biomarkers by qRT-PCR. RESULTS: Urolithins decreased media levels of nitric oxide, interleukin 6 (IL-6), prostaglandin E2, and tumor necrosis factor alpha from LPS-BV-2 microglia. In the co-culture cell model, media from LPS-BV-2 cells treated with urolithins preserved SH-SY5Y cell viability greater than media from cells treated without urolithins. Urolithins mitigated apoptosis and caspase 3/7 and 9 release from H2O2-induced oxidative stress of BV-2 and SH-SY5Y cells. While not statistically significant, inflammatory biomarkers (TNF-alpha, COX-2, IL-1, and IL-6) appeared to follow a decreasing trend in the hippocampus of high-dose PE-treated animals compared to controls. DISCUSSION: The attenuation of neuroinflammation by urolithins may contribute, in part, toward pomegranate's neuroprotective effects against AD.
28784051	12	24	ellagitannin	Chemical	MESH:C013515
28784051	60	70	urolithins	Chemical	-
28784051	80	97	neuroinflammation	Disease	MESH:D000090862
28784051	120	130	Urolithins	Chemical	-
28784051	132	144	ellagitannin	Chemical	MESH:C013515
28784051	256	275	Alzheimer's disease	Disease	MESH:D000544
28784051	277	279	AD	Disease	MESH:D000544
28784051	334	351	neuroinflammation	Disease	MESH:D000090862
28784051	387	397	urolithins	Chemical	-
28784051	399	417	urolithins A and B	Chemical	-
28784051	462	479	neuroinflammation	Disease	MESH:D000090862
28784051	483	489	murine	Species	10090
28784051	490	494	BV-2	CellLine	CVCL:0182
28784051	509	514	human	Species	9606
28784051	515	522	SH-SY5Y	CellLine	CVCL:0019
28784051	576	578	AD	Disease	MESH:D000544
28784051	580	585	R1.40	CellLine	CVCL:C2K0
28784051	587	591	mice	Species	10090
28784051	670	682	inflammatory	Disease	MESH:D007249
28784051	715	725	urolithins	Chemical	-
28784051	738	750	inflammatory	Disease	MESH:D007249
28784051	780	798	lipopolysaccharide	Chemical	MESH:D008070
28784051	800	803	LPS	Chemical	MESH:D008070
28784051	816	820	BV-2	CellLine	CVCL:0182
28784051	872	879	SH-SY5Y	CellLine	CVCL:0019
28784051	947	950	LPS	Chemical	MESH:D008070
28784051	951	955	BV-2	CellLine	CVCL:0182
28784051	986	996	urolithins	Chemical	-
28784051	1009	1019	urolithins	Chemical	-
28784051	1037	1054	caspase 3/7 and 9	Gene	836;840;842
28784051	1068	1072	H2O2	Chemical	MESH:D006861
28784051	1101	1105	BV-2	CellLine	CVCL:0182
28784051	1110	1117	SH-SY5Y	CellLine	CVCL:0019
28784051	1196	1201	R1.40	CellLine	CVCL:C2K0
28784051	1202	1206	mice	Species	10090
28784051	1245	1257	inflammatory	Disease	MESH:D007249
28784051	1290	1300	Urolithins	Chemical	-
28784051	1327	1339	nitric oxide	Chemical	MESH:D009569
28784051	1341	1354	interleukin 6	Gene	3569
28784051	1356	1360	IL-6	Gene	3569
28784051	1363	1379	prostaglandin E2	Chemical	MESH:D015232
28784051	1385	1412	tumor necrosis factor alpha	Gene	7124
28784051	1418	1421	LPS	Chemical	MESH:D008070
28784051	1422	1426	BV-2	CellLine	CVCL:0182
28784051	1479	1482	LPS	Chemical	MESH:D008070
28784051	1483	1487	BV-2	CellLine	CVCL:0182
28784051	1507	1517	urolithins	Chemical	-
28784051	1528	1535	SH-SY5Y	CellLine	CVCL:0019
28784051	1597	1607	urolithins	Chemical	-
28784051	1609	1619	Urolithins	Chemical	-
28784051	1644	1661	caspase 3/7 and 9	Gene	836;840;842
28784051	1675	1679	H2O2	Chemical	MESH:D006861
28784051	1708	1712	BV-2	CellLine	CVCL:0182
28784051	1717	1724	SH-SY5Y	CellLine	CVCL:0019
28784051	1769	1781	inflammatory	Disease	MESH:D007249
28784051	1794	1803	TNF-alpha	Gene	21926
28784051	1805	1810	COX-2	Gene	17709
28784051	1812	1816	IL-1	Gene	3552
28784051	1822	1826	IL-6	Gene	3569
28784051	1970	1987	neuroinflammation	Disease	MESH:D000090862
28784051	1991	2001	urolithins	Chemical	-
28784051	2080	2082	AD	Disease	MESH:D000544
28784051	Association	MESH:D007249	3552
28784051	Association	MESH:D006861	836
28784051	Association	MESH:D006861	840
28784051	Association	MESH:D007249	21926
28784051	Association	MESH:D007249	17709
28784051	Association	MESH:D006861	842
28784051	Negative_Correlation	MESH:C013515	MESH:D000090862
28784051	Negative_Correlation	MESH:C013515	MESH:D000544

